MATTHEW DETTRA: Open Payments
NPI 1760041636 · FORT WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,381 in 137 payments from 16 companies in 2025. Trend: 2023 $2,002 · 2024 $2,674 · 2025 $2,381
Food & beverage: $2,376Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $527 |
| ABBVIE INC. | 33 | $437 |
| GENZYME CORPORATION | 7 | $260 |
| Regeneron Healthcare Solutions, Inc. | 5 | $184 |
| PFIZER INC. | 17 | $158 |
| Lilly USA, LLC | 9 | $142 |
| Incyte Corporation | 5 | $130 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $120 |
| Organon LLC | 10 | $102 |
| Galderma Laboratories, L.P. | 5 | $89 |
Products named: TREMFYA, DUPIXENT, RINVOQ, SKYRIZI, CIBINQO, TALTZ, OPZELURA, ILUMYA.
Industry payments across PA — which companies pay providers there.
